Anabel is a Reporter, working across the six Citeline publications. She is a recent graduate from the University of Exeter and holds a BA English degree. Since graduating, Anabel has also completed an editorial internship with the In Vivo team. Before joining Norstella she spent the past year as Editor-in-Chief of her university’s student paper, Exeposé, managing an editorial team to produce a 32-page paper on a fortnightly basis.
Latest from Anabel Costa-Ferreira
Stay up to date on regulatory guidelines from around the world with the Pink Sheet’s Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.
The highlights of recent comments and insights from industry executives on the key issues covered in Scrip.
Findings from a new report on electronic Product Information pilots projects in Europe reveal a landscape of innovation, collaboration and cautious optimism, according to a group of pharmaceutical industry bodies.
Findings from a new report on electronic Product Information pilots projects in Europe reveal a landscape of innovation, collaboration and cautious optimism, according to a group of pharmaceutical industry bodies.
Renée Aguiar-Lucander, CEO of Hansa Biopharma, discussed the company’s leading asset, its journey toward US FDA approval and the trials and tribulations of completing a Phase III program.